EUVIMEDEUVIMED entdecken
Open Access

The Endogenous Retinoic Acid Receptor Pathway Is Exploited by Mycobacterium tuberculosis during Infection, Both In Vitro and In Vivo

Yonne Karoline Tenório de Menezes iD, Carolina Eto, Joseana de Oliveira iD, Erica C Larson iD, Daniel A G B Mendes iD, Greicy Brisa Malaquias Dias, Murilo Delgobo iD, Abigail K Gubernat, Janelle L Gleim, Eduarda Laís Munari, Marick Starick iD, Fabienne Ferreira iD und 4 weitere

The Journal of Immunology · 2023

DOI: 10.4049/jimmunol.2200555 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, 2023. Verfasst von Yonne Karoline Tenório de Menezes und 15 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Immunobiology, Department of Microbiology, Immunology and Parasitology, Federal University of Santa Catarina, Florianópolis, Brazil. Hauptthemen laut MEDLINE: Receptors, Retinoic Acid, Mycobacterium tuberculosis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NIAID NIH HHS, Howard Hughes Medical Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Retinoic acid (RA) is a fundamental vitamin A metabolite involved in regulating immune responses through the nuclear RA receptor (RAR) and retinoid X receptor. While performing experiments using THP-1 cells as a model for Mycobacterium tuberculosis infection, we observed that serum-supplemented cultures displayed high levels of baseline RAR activation in the presence of live, but not heat-killed, bacteria, suggesting that M. tuberculosis robustly induces the endogenous RAR pathway. Using in vitro and in vivo models, we have further explored the role of endogenous RAR activity in M. tuberculosis infection through pharmacological inhibition of RARs. We found that M. tuberculosis induces classical RA response element genes such as CD38 and DHRS3 in both THP-1 cells and human primary CD14+ monocytes via a RAR-dependent pathway. M. tuberculosis–stimulated RAR activation was observed with conditioned media and required nonproteinaceous factor(s) present in FBS. Importantly, RAR blockade by (4-[(E)-2-[5,5-dimethyl-8-(2-phenylethynyl)-6H-naphthalen-2-yl]ethenyl]benzoic acid), a specific pan-RAR inverse agonist, in a low-dose murine model of tuberculosis significantly reduced SIGLEC-F+CD64+CD11c+high alveolar macrophages in the lungs, which correlated with 2× reduction in tissue mycobacterial burden. These results suggest that the endogenous RAR activation axis contributes to M. tuberculosis infection both in vitro and in vivo and reveal an opportunity for further investigation of new antituberculosis therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Retinoic AcidMycobacterium tuberculosisMiceHumansAnimalsDrug Inverse AgonismTretinoinRetinoid X Receptors

Substanzen

Receptors, Retinoic AcidTretinoinRetinoid X Receptors

Autor:innen und Institutionen

  • Laboratory of Immunobiology, Department of Microbiology, Immunology and Parasitology, Federal University of Santa Catarina, Florianópolis, Brazil.
  • Department of Biochemistry and Immunology, Graduate Program in Basic and Applied Immunology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA.
  • Department of Internal Medicine I, University Hospital Würzburg, Würzburg, Germany.
  • Laboratory of Molecular Genetics of Bacteria, Department of Microbiology, Immunology and Parasitology, Federal University of Santa Catarina, Florianópolis, Brazil.

ORCID-Profile: Yonne Karoline Tenório de Menezes, Joseana de Oliveira, Erica C Larson, Daniel A G B Mendes, Murilo Delgobo, Marick Starick, Fabienne Ferreira, Daniel Santos Mansur, Diego L Costa, Charles A Scanga, André Báfica

Förderung

  • NIH HHS
  • NIAID NIH HHS
  • Howard Hughes Medical Institute
  • HHMI
  • NIH

Zitieren

APA

Tenório de Menezes, Y. K., Eto, C., de Oliveira, J., Larson, E. C., Mendes, D. A. G. B., Dias, G. B. M., Delgobo, M., Gubernat, A. K., Gleim, J. L., Munari, E. L., Starick, M., Ferreira, F., Mansur, D. S., Costa, D. L., Scanga, C. A., & Báfica, A. (2023). The Endogenous Retinoic Acid Receptor Pathway Is Exploited by Mycobacterium tuberculosis during Infection, Both In Vitro and In Vivo. The Journal of Immunology. https://doi.org/10.4049/jimmunol.2200555

Vancouver

Tenório de Menezes YK, Eto C, de Oliveira J, Larson EC, Mendes DAGB, Dias GBM, et al. The Endogenous Retinoic Acid Receptor Pathway Is Exploited by Mycobacterium tuberculosis during Infection, Both In Vitro and In Vivo. The Journal of Immunology. 2023. doi:10.4049/jimmunol.2200555

BibTeX
@article{TenriodeMenezes2023,
  author = {Tenório de Menezes, Yonne Karoline and Eto, Carolina and de Oliveira, Joseana and Larson, Erica C and Mendes, Daniel A G B and Dias, Greicy Brisa Malaquias and Delgobo, Murilo and Gubernat, Abigail K and Gleim, Janelle L and Munari, Eduarda Laís and Starick, Marick and Ferreira, Fabienne and Mansur, Daniel Santos and Costa, Diego L and Scanga, Charles A and Báfica, André},
  title = {The Endogenous Retinoic Acid Receptor Pathway Is Exploited by Mycobacterium tuberculosis during Infection, Both In Vitro and In Vivo},
  journal = {The Journal of Immunology},
  year = {2023},
  doi = {10.4049/jimmunol.2200555}
}
Kostenlos starten →